New 3D Bio-Printing Lab – 3D Printing Venture Capital Available – Top 10 3D Printing Investors

Posted by on Apr 18, 2018 in 3D Printing, Biotech, Business, Investing, Metal 3D Printing, Technology

New 3D Bio-Printing Lab – 3D Printing Venture Capital Available – Top 10 3D Printing Investors

New 3D Bio-Printing Lab – 3D Printing Venture Capital Available – Top 10 3D Printing Investors Johnson & Johnson Collaborates With AMBER to Open New 3D Bio-Printing Lab Johnson & Johnson collaborates with AMBER Research group in a new bio-printing venture. The two illustrious companies are looking to set-up this lab within Trinity College Dublin. They began preparations within the first quarter of this year and hope to open it by the end of 2018. Professor Michael Morris, AMBER director has called the lab “a global center of excellence for Bio 3D printing“. READ MORE 3D Printing Venture Capital Available I’m working with an investment group whose members have over 20 years each in the public markets, have raised millions of dollars for various companies across multiple sectors, and have significant capital ready to invest… READ MORE   Who is funding the startups that will give you your first 3D printed house? First and foremost is the fact that contrary to the investors funding most of the major digital technology driven innovations, the top 3D printing investors have a strong international component. Here we look at the 10 top 3D printing investors ranked by how much they invested in startups in that space… READ...

Read More »

3D Printing Stocks – And What Is Happening With 3D Printing Firm Organovo?

Posted by on Aug 6, 2015 in Biotech, Business

3D Printing Stocks – And What Is Happening With 3D Printing Firm Organovo?

The recent slide over the last few weeks has been spawned from the company’s latest secondary offering in which they raised an additional $40 million at a $4.25 share price. This struck a nerve with investors and provided yet another opportunity to rake in the profits. While the market didn’t love this news, in my opinion, as well as that of the company, this was a move to insure that Organovo remains a market leader within the bioprinting space. With around $90 million in cash on hand and no debt, Organovo now has a balance sheet which would make any biotech company envious. While analysts don’t expect the company to realize a profit until sometime in 2019, the magnitude of what Organovo is trying to do certainly makes their market cap of $345 million seem appealing, especially when the company recently estimated their current planned areas of research could lead to $400+ in annual revenue in the long run. Nothing is a certainly, especially in the bioprinting industry, much less the 3D printed biotech industry, but Organovo has a significant lead on the competition and has built a strong foundation for future success with partnerships with companies like L’Oréal and Merck. Any hint at a wildly successful product, either through these partnerships or their own R&D, could lead to a $1 billion+ buyout offer in the long run even if the company is not yet...

Read More »

Cambrian Genomics

Posted by on Nov 23, 2013 in Biotech, Startups

Cambrian Genomics

Cambrian Genomics makes the first hardware/systems for DNA laser printing. Researchers in academia and industry order or clone over $1b/year of DNA. Cambrian Genomics plans to deliver high quality sequence verified DNA to buyers in this existing and growing worldwide market. Founders Austen Heinz – CEO of Cambrian Genomics Reese Jones John Mulligan Anselm Levskaya Lukman Winoto Sagar Indurkhya George...

Read More »